Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;38:683-687

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by García, S. I.
Right arrow Articles by Pirola, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by García, S. I.
Right arrow Articles by Pirola, C. J.
Related Collections
Right arrow Clinical genetics
Right arrow Other hypertension
Right arrow Hypertension - basic studies
Right arrow Epidemiology

(Hypertension. 2001;38:683.)
© 2001 American Heart Association, Inc.


Endocrine Systems

Thyrotropin-Releasing Hormone Receptor (TRHR) Gene Is Associated With Essential Hypertension

Silvia I. García; Patricia I. Porto; Guillermo Dieuzeide; María S. Landa; Tobias Kirszner; Yanquel Plotquin; Claudio Gonzalez; Carlos J. Pirola

From the Laboratorio de Cardiología Molecular, Instituto de Investigaciones Médicas "A Lanari" (S.I.G., P.I.P, M.S.L., C.J.P.); Departamento de Farmacología, Facultad de Medicina, Universidad de Buenos Aires (C.G.); Centro para el Estudio y Tratamiento de la Hipertensión Arterial, Hospital Zubizarreta (T.K., Y.P.), Buenos Aires; and CAIDEM (G.D.), Chacabuco (Pcia de Buenos Aires), Argentina.

Correspondence to Dr Carlos J. Pirola, Instituto de Investigaciones Médicas "A. Lanari," Combatientes de Malvinas 3150, Capital Federal (1427), Argentina. E-mail cjpirola{at}ciudad.com.ar

Abstract

Abstract— In essential hypertension, a polygenic and multifactorial syndrome, several genes interact with the environment to produce high blood pressure. Thyrotropin-releasing hormone (TRH) plays an important role in central cardiovascular regulation. We have described that TRH overexpression induces hypertension in a normal rat, which was reversed by TRH antisense treatment. This treatment also reduces the central TRH hyperactivity in spontaneously hypertensive rats and normalizes blood pressure. Human TRH receptor (TRHR) belongs to the G protein-coupled seven-transmembrane domain receptor superfamily. Mutations of these receptors may result in constitutive activation. As it has been demonstrated that hypertensive patients have a blunted TSH response to TRH injection, suggesting a defect in the TRHR, we postulate that the TRHR gene is involved in human hypertension. We studied 2 independent populations from different geographic regions of our country: a sample of adult subjects from a referral clinic and a population-based sample of high school students. In search of molecular variants of TRHR, we disclosed that a polymorphic TG dinucleotide repeat (STR) at -68 bp and a novel single nucleotide polymorphism, a G->C conversion at -221 located in the promoter of the TRHR are associated with essential hypertension. As STRs detected in gene promoters are potential Z-DNA-forming sequences and seem to affect gene expression, we studied the potentially different transcriptional activity of these TRHR promoter variants and found that the S/-221C allele has a higher affinity than does the L/G-221 allele to nuclear protein factor(s). Our findings support the hypothesis that the TRHR gene participates in the etiopathogenesis of essential hypertension.


Key Words: epidemiology • genes • hypertension, essential • hormone • thyroliberin • receptor




This article has been cited by other articles:


Home page
HypertensionHome page
O. Gumieniak, T. S. Perlstein, J. S. Williams, P. N. Hopkins, N. J. Brown, B. A. Raby, and G. H. Williams
Ala92 Type 2 Deiodinase Allele Increases Risk for the Development of Hypertension
Hypertension, March 1, 2007; 49(3): 461 - 466.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
O. Gumieniak, S. Hurwitz, T. S. Perlstein, U. C. Ngumezi, P. N. Hopkins, X. Jeunemaitre, and G. H. Williams
Aggregation of High-Normal Thyroid-Stimulating Hormone in Hypertensive Families
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5985 - 5990.
[Abstract] [Full Text] [PDF]